Insights On Enterprise Solutions

  1. Rentschler Biopharma Capabilities Update June 2026: Cell Line Development 6/19/2026

    Next-gen CMC uses high-performing cell lines to accelerate timelines, improve consistency, and scale efficiently, leveraging gains in stability, pool quality, and process intensification.

  2. Structuring ADC Analytical Partnerships From Pre-IND To Commercial 6/17/2026

    ADC success depends less on molecular design than on a continuous analytical strategy that connects early characterization to late-stage control, preventing variability, data gaps, and regulatory issues from compounding over time.

  3. Accelerating Biologics With Seamless Technology Transfer 6/17/2026

    Discover how effective technology transfer strategies can streamline scale-up, maintain product quality, and enable successful clinical and commercial manufacturing.

  4. Simplifying ADC Development Through CDMO Collaboration 6/17/2026

    Two CDMOs are working together to simplify ADC development. Learn how integrated support and collaboration can reduce complexity, streamline transfers, and keep programs moving forward.

  5. BIOSECURE, Tariffs, And The New CDMO Reality For Biopharma Innovators 6/16/2026

    Secure domestic or diversified biopharma manufacturing to protect therapeutic development from supply chain disruptions, rising costs, and legislative tariff impacts.

  6. Elevate Your Protein Production With SynWeave™ 6/15/2026

    Sunit Maity, Ph.D., Senior GM – Biologics Services, introduces an advanced platform that combines state-of-the-art cell line and transposon-based technologies from ExcellGene.

  7. Integrated DS-DP Manufacturing For Your Biologics 6/15/2026

    Discover how next-generation biologics manufacturing can help accelerate your path from molecule to market with the scale, speed, and flexibility needed to support your program at every stage.

  8. Biologics DS Manufacturing Facility Across The U.S. And India 6/15/2026

    Our integrated setup enables seamless progression from early-stage development to commercial production, providing flexibility, scalability, and operational efficiency to accelerate biologics programs and support evolving market demands.

  9. Biologics DP Manufacturing Facility — 1M Vials Per Day 6/15/2026

    Our facility features two high-speed vial filling lines capable of producing up to one million vials per day, accommodating fill volumes ranging from 1 mL to 100 mL across a broad range of biologic products.

  10. 3 Key Considerations When Choosing A Partner For Your Tech Transfer 6/15/2026

    One way to streamline tech transfer is to partner with a CMO demonstrating a proven track record across the entire drug development and manufacturing continuum.